SCHEMBL1018513

SCHEMBL1018513

O=C(O)c1ccc(C(=O)N2CCOCC2)nc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.83
ALDH1A1 P00352 2/20 0.57
P4HA1 P13674 1/20 0.54
MIF P14174 1/20 0.54
P4HTM Q9NXG6 1/20 0.54
POLB P06746 3/20 0.53
GRM5 P41594 2/20 0.52
HPGD P15428 4/20 0.51
PRKAA2 P54646 2/20 0.51
PRKAB2 O43741 1/20 0.51
PRKAG1 P54619 1/20 0.51
PRKAA1 Q13131 1/20 0.51
PRKAG3 Q9UGI9 1/20 0.51
PRKAG2 Q9UGJ0 1/20 0.51
PRKAB1 Q9Y478 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
L3MBTL3 Q96JM7 1/20 0.50
PHGDH O43175 1/20 0.50
KDM4E B2RXH2 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13210615 0.91 SMN1; SMN2 (1.00) SMN1; SMN2ALDH1A1POLBGRM5HPGD
SCHEMBL6742231 0.88 SMN1; SMN2 (0.83) SMN1; SMN2ALDH1A1P4HA1MIFP4HTM
SCHEMBL7562739 0.87 SMN1; SMN2 (0.81) SMN1; SMN2ALDH1A1POLBGRM5HPGD
SCHEMBL17559403 0.87 SMN1; SMN2 (0.81) SMN1; SMN2ALDH1A1P4HA1MIFP4HTM
SCHEMBL17560132 0.84 L3MBTL3 (0.59) SMN1; SMN2ALDH1A1P4HA1MIFP4HTM
SCHEMBL1017672 0.83 SMN1; SMN2 (0.74) SMN1; SMN2ALDH1A1POLBGRM5HPGD
SCHEMBL3227298 0.80 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1GRM5HPGDPHGDH
SCHEMBL15008288 0.80 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1GRM5HPGDPRKAA2
SCHEMBL2379474 0.80 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1GRM5HPGDPHGDH
SCHEMBL7877444 0.80 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1GRM5HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116872-A1 PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2024-04-11 US disclosed
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2023-08-24 US disclosed
US-20230110165-A1 Substituted Imidazo[4,5-c]pyridine Compounds and Compositions Thereof PROXIMAGEN LLC (US) 2023-04-13 US disclosed
US-11512082-B2 Substituted imidazo[4,5-c]pyridine compounds and compositions thereof PROXIMAGEN, LLC (US) 2022-11-29 US disclosed
US-10968223-B2 Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors PROXIMAGEN, LLC (US) 2021-04-06 US disclosed
US-20210070707-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2021-03-11 US disclosed
US-20200347059-A1 IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS PROXIMAGEN, LLC (US) 2020-11-05 US disclosed
US-10766897-B2 Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors PROXIMAGEN, LLC (US) 2020-09-08 US disclosed
US-20200262835-A1 COMPOUNDS PROXIMAGEN, LLC (US) 2020-08-20 US disclosed
US-20200190030-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2020-06-18 US disclosed
CN-1152910-A Difluorostatone antiviral agents MERRELL PHARMA INC (US) 1997-06-25 CN disclosed
WO-1997020856-A1 ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES HOECHST MARION ROUSSEL, INC. (US) 1997-06-12 WO disclosed
EP-0773926-A1 DIFLUOROSTATONE ANTIVIRAL AGENTS MERRELL PHARMACEUTICALS INC. (US) 1997-05-21 EP disclosed
EP-0763055-A1 PERFLUOROALKYL KETONE INHIBITORS OF ELASTASE AND PROCESSES FOR MAKING THE SAME MERRELL PHARMACEUTICALS INC. (US) 1997-03-19 EP disclosed
EP-0762887-A1 ACYLATED ENOL DERIVATIVES AS PRODRUGS OF ELASTASE INHIBITORS MERRELL PHARMACEUTICALS INC. (US) 1997-03-19 EP disclosed
WO-1996021655-A2 SUBSTITUTED OXAZOLIDINE CALPAIN AND/OR CATHEPSIN B INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1996-07-18 WO disclosed
WO-1996002499-A1 DIFLUOROSTATONE ANTIVIRAL AGENTS MERRELL PHARMACEUTICALS INC. (US) 1996-02-01 WO disclosed
WO-1995033763-A1 NOVEL ELASTASE INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1995-12-14 WO disclosed
WO-1995033762-A1 PERFLUOROALKYL KETONE INHIBITORS OF ELASTASE AND PROCESSES FOR MAKING THE SAME MERRELL PHARMACEUTICALS INC. (US) 1995-12-14 WO disclosed
WO-1995033478-A1 ACYLATED ENOL DERIVATIVES AS PRODRUGS OF ELASTASE INHIBITORS MERRELL PHARMACEUTICALS INC. (US) 1995-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11512082-B2 Substituted imidazo[4,5-c]pyridine compounds and compositions thereof PNPO, XDH, EPX SMN1; SMN2 618/4885ALDH1A1 489/4885P4HA1 707/4885
US-20200190030-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO SMN1; SMN2 4094/4885ALDH1A1 2407/4885P4HA1 203/4885
US-10766897-B2 Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors PNPO, SSB, XDH SMN1; SMN2 895/4885ALDH1A1 730/4885P4HA1 318/4885
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO SMN1; SMN2 4094/4885ALDH1A1 2407/4885P4HA1 203/4885
US-20240116872-A1 PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING SHH, GLI1, SMO SMN1; SMN2 4106/4885ALDH1A1 2371/4885P4HA1 239/4885
US-20210070707-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO SMN1; SMN2 4094/4885ALDH1A1 2407/4885P4HA1 203/4885
US-10968223-B2 Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors PNPO, PPOX, SCO2 SMN1; SMN2 762/4885ALDH1A1 198/4885P4HA1 425/4885
US-20230110165-A1 Substituted Imidazo[4,5-c]pyridine Compounds and Compositions Thereof PNPO, XDH, EPX SMN1; SMN2 618/4885ALDH1A1 489/4885P4HA1 707/4885
US-20200347059-A1 IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS PNPO, PPOX, SCO2 SMN1; SMN2 762/4885ALDH1A1 198/4885P4HA1 425/4885
US-20200262835-A1 COMPOUNDS QSOX1, AOX1, EPX SMN1; SMN2 1098/4885ALDH1A1 501/4885P4HA1 1103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.